Qube Research & Technologies (QRT)
CAPR icon

Qube Research & Technologies (QRT)’s Capricor Therapeutics CAPR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,433
Closed -$68.8K – 3376
2024
Q2 		$68.8K Sell
14,433
-54,970
-79% -$307K ﹤0.01% 2673
2024
Q1 		$471K Buy
69,403
+14,394
+26% +$69.6K ﹤0.01% 2568
2023
Q4 		$269K Buy
55,009
+49,380
+877% +$161K ﹤0.01% 2637
2023
Q3 		$19.3K Buy
+5,629
New +$31.6K ﹤0.01% 3158

Other funds holding CAPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CAPR Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Capricor Therapeutics (CAPR) in Q3 2024, closing a stake of 14,433 shares — an estimated $68.8K sold.

Qube Research & Technologies (QRT) first reported a position in CAPR in Q3 2023 and held it in 4 quarters. The position peaked at $471K in Q1 2024. 75 funds tracked by Wall St. Rank hold CAPR as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Capricor Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 14,433 Capricor Therapeutics shares in Q3 2024, an estimated $68.8K.
  • Qube Research & Technologies (QRT) first reported a position in Capricor Therapeutics in Q3 2023 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s Capricor Therapeutics position peaked at $471K in Q1 2024.
  • 75 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.